These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18271143)

  • 1. Hybrid imaging: which road to go?
    Otte A
    Hell J Nucl Med; 2007; 10(3):181. PubMed ID: 18271143
    [No Abstract]   [Full Text] [Related]  

  • 2. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades.
    Basu S; Alavi A
    J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging in oncology. Preface.
    Cancer Treat Res; 2008; 143():v. PubMed ID: 18619211
    [No Abstract]   [Full Text] [Related]  

  • 4. High standards.
    Holbrook DS
    J Nucl Med; 2006 Jul; 47(7):35N. PubMed ID: 16871698
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimizing and communicating radiation risk in pediatric nuclear medicine.
    Fahey FH; Treves ST; Adelstein SJ
    J Nucl Med; 2011 Aug; 52(8):1240-51. PubMed ID: 21764783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
    Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
    Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN; Greene GS
    Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ich bin ein Molekularmediziner (how much CT and nuclear medicine in molecular CT?).
    Mansi L
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):531-2. PubMed ID: 19139881
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical PET in oncology: not only FDG.
    Nanni C; Rubello D; Al-Nahhas A; Fanti S
    Nucl Med Commun; 2006 Sep; 27(9):685-8. PubMed ID: 16894321
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L; Salvatore M; Del Vecchio S
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular imaging: thriving all over the world.
    Wagner HN
    J Nucl Med; 2007 Aug; 48(8):15N-16N, 19N-38N. PubMed ID: 17673419
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: Current issues in nuclear cardiology.
    Tonge CM; Fernandez RC; Harbinson MT
    Br J Radiol; 2008 Apr; 81(964):270-4. PubMed ID: 18250120
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of noninvasive imaging for hypertrophic cardiac syndromes and restrictive physiology.
    Fowler SJ; Narula J; Gurudevan SV
    Heart Fail Clin; 2006 Apr; 2(2):215-30. PubMed ID: 17386891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.